TSE:GEN GeneNews (GEN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About GeneNews Stock (TSE:GEN) 30 days 90 days 365 days Advanced Chart Get GeneNews alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume473,147 shsAverage Volume1.48 million shsMarket CapitalizationC$25.49 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGeneration Uranium Inc. engages in the exploration and development of mineral properties. It has an option agreement to acquire a 60% interest in the Arlington property that comprises five mineral claims located in the Arrow Boundary District of south-central British Columbia, Canada; and holds a 100% interest in the YATH Uranium Property comprises five mineral claims that totaling approximately 8,438 hectares located in the territory of Nunavut. The company was formerly known as Generation Gold Corp. and changed its name to Generation Uranium Inc. in January 30, 2024. Generation Uranium Inc. was incorporated in 2018 and is based in Vancouver, Canada.Read More… Receive GEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GeneNews and its competitors with MarketBeat's FREE daily newsletter. Email Address GEN Stock News HeadlinesGeneNews: Q1 Earnings SnapshotMay 16, 2024 | washingtonpost.comVertex, Crispr Get Second FDA Approval for Gene TherapyJanuary 18, 2024 | msn.comThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.May 25, 2025 | Paradigm Press (Ad)Gene-editing treatment from Vertex and CRISPR cleared for second rare blood disorderJanuary 17, 2024 | msn.comFDA expands use of newly approved CRISPR therapyJanuary 17, 2024 | msn.comOhio St hires Texas A&M athletic director Ross Bjork to replace the retiring Gene SmithJanuary 16, 2024 | washingtonpost.comMutated gene thought to exist in just 4% of people could ‘help tackle obesity’November 27, 2023 | msn.comSickle-Cell Treatment Created With Gene Editing Wins U.K. ApprovalNovember 18, 2023 | nytimes.comSee More Headlines GEN Stock Analysis - Frequently Asked Questions How do I buy shares of GeneNews? Shares of GEN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of GeneNews own? Based on aggregate information from My MarketBeat watchlists, some other companies that GeneNews investors own include MARA (MARA), Ocugen (OCGN), Spero Therapeutics (SPRO), American Airlines Group (AAL), First Majestic Silver (AG) and Antibe Therapeutics (ATE). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Diagnostics & Research Sub-IndustryComputer Software Current SymbolTSE:GEN CIKN/A Webwww.genenews.com Phone+1-905-7392030FaxN/AEmployees2,700Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.10 Quick Ratio0.05 Sales & Book Value Annual SalesC$234,592.00 Price / Sales0.00 Cash FlowN/A Price / Cash Flow145.00 Book ValueC($0.06) per share Price / BookN/AMiscellaneous Outstanding Shares169,963,000Free FloatN/AMarket CapC$25.49 million OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (TSE:GEN) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneNews Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneNews With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.